The FDA Modernization Act 2.0: Drug Testing in Animals is Rendered Optional

被引：17

作者：

Adashi, Eli Y. ^{[1
,4
]}

O'Mahony, Daniel P. ^{[2
]}

Cohen, I. Glenn ^{[3
]}

机构：

[1] Brown Univ, Dept Med & Biol Sci, Providence, RI USA

[2] Brown Univ Lib, Lib Planning & Assessment, Providence, RI USA

[3] Harvard Univ, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioet, Harvard Law Sch, Cambridge, MA USA

[4] Brown Univ, Med & Biol Sci, 222 Richmond St, Providence, RI 02903 USA

来源：

AMERICAN JOURNAL OF MEDICINE | 2023年 / 136卷 / 09期

关键词：

D O I：

10.1016/j.amjmed.2023.03.033

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：853 / 854

页数：2

共 50 条

[41] The Medicare Prescription Drug Improvement and Modernization Act and the delivery of cancer chemotherapy
Downs, Christian
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (15) : S13 - S15
[42] Food and drug administration modernization act of 1997: Medical device provisions
Pilot, LR
Waldmann, DR
FOOD AND DRUG LAW JOURNAL, 1998, 53 (02): : 267 - 295
[43] The US Food and Drug Administration Modernization Act of 1997: Impact on consumers
Golodner, LF
CLINICAL THERAPEUTICS, 1998, 20 : C20 - C25
[44] Effect of the Medicare Prescription Drug Improvement and Modernization Act on the bottom line
Jarrett, Anne T.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2006, 63 : S10 - S13
[45] Medicaid drug spending after the Medicare Modernization Act: What will be left?
Boulanger, L
Brown, J
Menzin, J
VALUE IN HEALTH, 2005, 8 (03) : 237 - 237
[46] Pharmacy implications of the medicare prescription drug, improvement, and modernization act of 2003
Okafor, MC
ANNALS OF PHARMACOTHERAPY, 2004, 38 (10) : 1747 - 1749
[47] FDA MAY REDUCE ANIMAL DEATHS IN DRUG TESTING
Cima, Greg
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2019, 254 (02): : 175 - 175
[48] Regulatory toxicity testing and the Animals (Scientific procedures) Act 1986
不详
ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 1996, 24 (01): : 111 - 117
[49] Changes to the Hatch-Waxman Act following the "Medicare Prescription Drug, Improvement and Modernization Act of 2003"
Marenberg, BJ
BIOTECHNOLOGY LAW REPORT, 2004, 23 (03) : 277 - 280
[50] US FDA Modernization Act, Section 114Uses, Opportunities and Implications for Comparative Effectiveness Research
Peter J. Neumann
Pei-Jung Lin
Tom E. Hughes
PharmacoEconomics, 2011, 29 : 687 - 692

← 1 2 3 4 5 →